StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Cash

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on May 17, 2021 9:21am

82 Views

Post# 33213104

RE:Cash

Yup. Those who understand financials are seeing historical losses screeching to a halt as revenues grow!
(there have been losses every quarter so far, and with share prices far higher than this!)
Next quarters, with accelerated Aristotle implementation and multiplying (4x, 5x, 10x, etc.) Covid testing for travel revenues should see us in the black!
Buh-bye, Johnny, DizzyWizzy, and the other bashers! The earnings trajectory is UP, and with you idiots gone, that's where the share price is going, too!
GLTA longs!